ProShare Advisors’s Zura Bio ZURA Stock Holding History

ProShare Advisors’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,927	Closed	-$14.1K	–	2200
2025 Q1	$14.1K	Sell	10,927 -2,967	-21%	-$4.68K	﹤0.01%	2053
2024 Q4	$34.7K	Buy	+13,894	New	+$49.5K	﹤0.01%	2225

Other funds holding ZURA

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

ProShare Advisors's ZURA Position: Q2 2025 in Review

ProShare Advisors sold out of Zura Bio (ZURA) in Q2 2025, closing a stake of 10,927 shares — an estimated $14.1K sold.

ProShare Advisors first reported a position in ZURA in Q4 2024 and held it in 2 quarters. The position peaked at $34.7K in Q4 2024. 65 funds tracked by Wall St. Rank hold ZURA as of Q2 2025.

ProShare Advisors reported no remaining Zura Bio position as of Q2 2025 after selling out during the quarter.
ProShare Advisors sold 10,927 Zura Bio shares in Q2 2025, an estimated $14.1K.
ProShare Advisors first reported a position in Zura Bio in Q4 2024 and held it in 2 quarters.
ProShare Advisors's Zura Bio position peaked at $34.7K in Q4 2024.
65 funds tracked by Wall St. Rank held Zura Bio as of Q2 2025.

Based on ProShare Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.